Drug Database
Back to search

Belgium· BE-AMP-SAM203892-00

Anginol Lidocaïne 0.25 mg - 1 mg

A lidocaine product containing dequalinium chloride, registered in Belgium by Vemedia Manufacturing. The same ATC class is registered in 7 of our 19 countries.

ATC R02AD02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAnginol Lidocaïne 0.25 mg - 1 mgATCR02AD02REGISTER NO.BE-AMP-SAM203892-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dequalinium chlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lidocaine is registered in 7 of 19 countries.

Countries holding a registration under ATC R02AD02 (lidocaine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search lidocaine products by name

Lidocaine · ATC R02AD02

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Italyprice
  • Netherlands
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Dequalinium Chloride
Manufacturer
Vemedia Manufacturing
Country
Belgium (BE)
ATC code
R02AD02
ATC class
Lidocaine
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3320298

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

39 interactions on record for lidocaine.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lidocaine against other medicinesHow interaction checks work

Lidocaine · interactions on record

39 records

  • 1 severe
  • 38 moderate

Most severe, free to view

  • PrilocaineN01BB04severe
  • MetoclopramideA03FA01moderate
  • SulfamethizoleB05CA04moderate
  • Glyceryl trinitrateC01DA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lidocaine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lidocaine products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Fluomizin, Tonsillol
  • Bulgaria · Флуомизин
  • Czechia · Naxyl
  • Germany · Dequalinium Chloride Ratiopharm, Fluomizin
  • Estonia · Donaxyl
  • Spain · Fluomizin
  • Finland · Donaxyl
  • France · Vablys
  • United Kingdom (Northern Ireland) · Fluomizin
  • Croatia · Fluomizin
  • Hungary · Fluomizin
  • Italy · Coryfin Gola, Dequadin
  • Lithuania · Donaxyl
  • Luxembourg · Fluomizin
  • Latvia · Donaxyl
  • Norway · Donaxyl
  • Poland · Fluomizin
  • Portugal · Fluomizin
  • Romania · Fluomizin
  • Sweden · Donaxyl
  • Slovenia · Fluomizin
  • Slovakia · Fluomizin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5b404df-f7e9-42b8-a11f-7fdd7786a007
GET /v1/drugs/c5b404df-f7e9-42b8-a11f-7fdd7786a007?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Compressed lozenge",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Anginol Lidocaïne 0.25 mg - 1 mg",
  "name_fr": "Anginol Lidocaïne 0.25 mg - 1 mg",
  "name_nl": "Anginol Lidocaïne 0.25 mg - 1 mg",
  "amp_code": "SAM203892-00",
  "strengths": [
    "0.2500",
    "0.2500",
    "1.0000",
    "1.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Dequalinium Chloride",
    "Lidocaine Hydrochloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Lidocaine",
  "authorisation_numbers": [
    "BE203892"
  ]
}
API referenceMCP serverPlans

See everything about lidocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console